Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant. (Q54607948)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Gustav Gaudernack

8

object named as

Gaudernack G

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

author name string

Hunger RE

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Brand CU

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Streit M

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Eriksen JA

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Gjertsen MK

5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Saeterdal I

6

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Braathen LR

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Experimental Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

10

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

161-167

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

The incidence of malignant melanoma in the United States: issues as we approach the 21st century

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Advances in specific immunotherapy of malignant melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Regulation of Ras-mediated signalling: more than one way to skin a cat.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Ras‐effector interactions, the problem of specificity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

21 January 2018

Prospective study of the incidence of melanoma in the Paris region in 1994. The PETRI Melanoma Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of CD4+ T cell responses in antitumor immunity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Overlapping epitopes encompassing a point mutation (12 Gly → Arg) in p21 ras can be recognized by HLA‐DR, ‐DP and ‐DQ restricted T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0625.2001.010003161.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0625.2001.010003161.X

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/11380611

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54607948&oldid=1452297418"